Paras Healthcare (PARASHLTH) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
27 Oct, 2026Executive summary
FY25 revenue from operations rose 14.62% YoY to INR 12,940.63 Mn; EBITDA was INR 1,564.60 Mn, with margin at 12.09% versus 13.68% in FY24.
Network expanded to 8 hospitals and 2,135 beds across five states and one union territory; new Srinagar and Kanpur hospitals contributed to capacity growth.
Consolidated results swung to a loss of INR 579.83 Mn from profit of INR 153.31 Mn in FY24, reflecting higher expenses, finance costs and depreciation.
Financial highlights
Consolidated total income rose to INR 13,142.07 Mn from INR 11,510.23 Mn; revenue from operations increased to INR 12,940.63 Mn from INR 11,290.39 Mn.
Consolidated PBT was a loss of INR 500.36 Mn versus profit of INR 66.30 Mn; net loss was INR 579.83 Mn versus INR 153.31 Mn, and EPS was -INR 5.94 versus -INR 1.57.
EBITDA was INR 1,564.60 Mn versus INR 1,544.11 Mn; EBITDA margin declined to 12.09% from 13.68%.
Finance costs rose 35.57% to INR 909.18 Mn; depreciation and amortisation increased 43.19% to INR 1,155.78 Mn, with Kanpur hospital capitalisation contributing to the increase.
Outlook and guidance
Targeting 2,935 beds by FY29; a 300-bed second Gurugram hospital is planned for FY28 and a 500-bed Ludhiana hospital for FY29.
Priorities include ramping occupancy at Srinagar, Kanpur, Ranchi and Udaipur, expanding advanced clinical programmes, improving length of stay and standardising procurement.
DNB postgraduate training spans 14 specialties and up to 48 students annually; expansion to Udaipur and Panchkula is planned.